Skip to main content
An official website of the United States government

The Personal Health Data Revolution, Connected Health, and Cancer

Meeting Information: March 26, 2015 | 8:00 a.m. - 4:00 p.m. | San Francisco, CA 94111

In this workshop, second in a series on connected health and cancer, the President’s Cancer Panel and leaders in various sectors will examine the role of personal health data as a driver of change in how individuals manage health and institutions conduct research. As more data are generated by health-tracking apps and devices, individuals and researchers are ready to use these data to the fullest potential. In many cases, user-generated data are being merged with other information sources to understand patterns in risk factors and population health. This exciting new era brings many opportunities for population health, health care, and research, but also challenges. Questions for exploration at this workshop include the following:

  • How do we generate knowledge from personal health data and then translate knowledge into health behavior change and improved health outcomes?
  • How can and do individuals use their own data for self-change? How do we leverage the collective input of Patient-Powered Networks for population change?
  • What is needed to optimize the flow of data? What standards are needed?
  • Who owns data generated by these applications?
  • What changes in informed consent are needed to reflect changes in the ways people contribute data for research, in online recruitment strategies for clinical trials, and in online communication among clinical trial participants?
  • What safeguards are needed to ensure both privacy and security?
  • What is required to move from a small number of elite institutions using multiple levels of data to inform prevention and care to a larger number of institutions implementing data-informed prevention and care?
  • How can challenges with current electronic health records be addressed to maximize benefits for patients? How should standards be developed and implemented?

This workshop is co-chaired by two national leaders in connected health. David K. Ahern, PhD, is Director, Program in Behavioral Informatics and eHealth, Brigham and Women's Hospital and Special Advisor, Division of Cancer Control and Population Sciences, National Cancer Institute. Bradford W. Hesse, PhD, is Chief, Health Communication and Informatics Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute.

Presentations and moderated discussions among participants will inform the Panel’s recommendations in a formal report to the President of the United States after the conclusion of series workshops.

Join us by live-tweeting during the workshop using #cHealth4Cancer (connected health for cancer).

Agenda

Time Agenda Item 
7:30 a.m. Registration
8:00 a.m. Welcome and Introductions
8:40 a.m

The Personal Health Data Landscape

Opening presentations (20 minutes)

  • Kevin Patrick, MD, Professor, Family and Preventive Medicine, University of California, San Diego, and Director, Center for Wireless and Population Health Systems, The Qualcomm Institute/Calit2
  • Christopher Boone, PhD, Executive Director, Health Data Consortium

Moderated discussion (50 minutes)

9:50 a.m. Break
10:05 a.m.

Personal Health Data for Individuals and Patients: Desired Future State for Individual Health Management Opening presentation (10 minutes)

  • John T. Wald, MD, Medical Director, Public Affairs and Marketing, Mayo Clinic

Moderated discussion (55 minutes)

11:10 a.m.

Personal Health Data for Cancer Detection and Care: Desired Future State for Health Care Opening presentation (20 minutes)

  • Stephen H. Friend, MD, PhD, President, Sage Bionetworks
  • Blackford Middleton, MD, MBA, MS Professor of Biomedical Informatics and of Medicine, Vanderbilt University School of Medicine

Moderated discussion (45 minutes)

12:15 p.m. Public Comment
12:20 p.m. Lunch
1:20 p.m.

Personal Health Data for Cancer Population Health: Desired Future State for Public Health

Opening presentation (10 minutes)

  • Nirav R. Shah, MD, MPH, Senior Vice President and Chief Operating Office, Quality and Operations, Kaiser Permanente Southern California

Moderated discussion (50 minutes)

2:20 p.m. Break
2:35 p.m.

Personal Health Data for Cancer Research: Desired Future State for Research Opening comments (20 minutes)

  • Richard L. Schilsky, MD, FASCO, Chief Medical Officer, American Society of Clinical Oncology
  • Urmimala Sarkar, MD, Associate Professor, Medicine in Residence, University of California, San Francisco

Moderated discussion (45 minutes)

3:40 p.m. Public Comment
3:45 p.m. Wrap Up and Next Steps
3:50 p.m. Adjourn

Participants

Name Title & Affiliations
Dr. David K. Ahern

Special Advisor
Health Communication and Informatics Research Branch
Division of Cancer Control and Population Sciences
National Cancer Institute
Rockville, MD
@dahern1

Dr. Christopher Boone

Executive Director
Health Data Consortium
Washington, DC
@cpboone

 

Ms. Janet Freeman-Daily

Lung Cancer Patient
Patient Advisory Board
Addario Lung Cancer Foundation
Federal Way, WA
@JFreemanDaily

Dr. Stephen H. Friend

President
Sage Bionetworks
Seattle, WA
@stephen_friend

Mr. Gilles J. Frydman

Chairman
Smart Patients
Mountain View, CA
@gfry

 

Ms. Sarah Greene

Associate Director
CER Methods & Infrastructure
Patient-Centered Outcomes
Research Institute
Washington, DC
@researchmatters

Dr. Bradford W. Hesse

Chief
Health Communication and
Informatics Research Branch
Division of Cancer Control and
Population Sciences
National Cancer Institute
Rockville, MD

Mr. Matthew Holt

Co-Chairman
Health 2.0
San Francisco, CA
@boltyboy

Dr. Warren A. Kibbe

Director
Center for Biomedical Informatics and Information Technology
National Cancer Institute
Rockville, MD
@wakibbe

 

Dr. George Komatsoulis Senior Bioinformatics Specialist
National Center for Biotechnology Information
National Library of Medicine
National Institutes of Health
Bethesda, MD
@gak1965
Ms. Heather Cooper Ortner

Chief Executive Officer
Dr. Susan Love Research Foundation
Santa Monica, CA
@HeatherOrtner

Dr. Blackford Middleton

Professor of Biomedical Informatics and
of Medicine
Vanderbilt University School of Medicine
Nashville, TN
@bfm

Ms. Judy Murphy

Chief Nursing Officer and Director
Global Business Services
IBM Healthcare
Washington, DC
@JudyMurphyHIT

 

Dr. Wendy Nilsen

Health Scientist Administrator
Office of Behavioral and Social Sciences Research
National Institutes of Health
Program Director
Smart and Connected Health
National Science Foundation
Bethesda, MD
@WendyNilsen

 

Dr. Kevin Patrick

Professor
Family and Preventive Medicine
University of California, San Diego
Director
Center for Wireless and Population Health Systems
The Qualcomm Institute/Calit2
La Jolla, CA

Dr. Barbara K. Rimer

Chair
President’s Cancer Panel
Dean and Alumni Distinguished Professor
University of North Carolina
Gillings School of Global Public Health
Chapel Hill, NC

Dr. Abby B. Sandler

Executive Secretary
President's Cancer Panel
Special Assistant to the Director
Rare Tumors Initiative
Center for Cancer Research
National Cancer Institute
Bethesda, MD

Dr. Urmimala Sarkar

Associate Professor
Medicine in Residence
University of California, San Francisco
San Francisco, CA
@UrmimalaSarkar

 

Dr. Richard L. Schilsky
 

Chief Medical Officer
American Society of Clinical Oncology
Alexandria, VA
@rschilsky

 

Dr. Nirav R. Shah

 

Senior Vice President
Chief Operating Officer
Quality and Operations
Kaiser Permanente Southern California
Pasadena, CA
@niravrshah

Ms. Emily S. Van Laar
 
Director
Oncology Medical Strategy
WebMD/Medscape
Savage, MN
@MedscapeOnc
Dr. John T. Wald
 
Medical Director
Public Affairs and Marketing
Mayo Clinic
Rochester, MN
@JohnWaldMD
Dr. Owen N. Witte
 

Member
President’s Cancer Panel
Distinguished Professor of Microbiology, Immunology, and Molecular Genetics
David Geffen School of Medicine
University of California, Los Angeles
Director
Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research
Los Angeles, CA

Summary

The President’s Cancer Panel held the second workshop in its series on connected health and cancer on March 26, 2015, in San Francisco, California. The workshop, entitled The Personal Health Data Revolution, Connected Health, and Cancer, brought together leaders in academia, technology, government, advocacy, and health care. Selected invitees delivered brief presentations, and participants discussed the current personal health data landscape and ways in which personal health data could be utilized for individual health management, health care, public health, and research.

Personal health data are being captured via an expanding and increasingly diverse set of devices, apps, services, and systems, ranging from wearable devices to social media and electronic health records. In addition to recording traditional medical data, these tools facilitate collection of information on social and environmental factors that has the potential to improve health and quality of life.

Workshop participants noted that enhanced access to and meaningful integration of personal health data could improve both quality of cancer care and quality of life for patients and enhance cancer control and prevention for individuals at risk of cancer. Moreover, they noted the role of connected health in facilitating both formal and informal communication on many levels. However, barriers to access and integration exist. Policies and practices often make it difficult for patients to access their own medical data and hamper data sharing among institutions and providers. Interoperable platforms needed to facilitate data integration, as well as common standards for personal health data, also are lacking. Importantly, data must be presented in meaningful ways to inform decision making by individuals and health care providers. When used optimally, integrated data systems should enhance patient engagement and patient-provider communication.

Participants discussed opportunities for research created by large-scale data integration. In addition to interoperable platforms and open-access policies, development of effective informed consent and deidentification processes would help researchers effectively utilize the wide range of personal health data being generated. New metrics and methods able to accommodate large, integrated data sets would complement traditional research methods. Several participants emphasized that research should be participatory and patient-centered, with patients involved in hypothesis generation, study design, and analysis.

Participants advocated for broad stakeholder involvement in efforts to achieve a connected health system, which will require action beyond the health care system. Findings and recommendations from the series will be presented in the Panel’s 2014–2015 Report to the President of the United States.

Download the full meeting summary.

  • Posted:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “The Personal Health Data Revolution, Connected Health, and Cancer was originally published by the National Cancer Institute.”

Email